These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 667820)

  • 61. Partial purification of a normal mice serum sugar-phosphatase inhibitor from cell-free ascites fluids of lymphoma-bearing mice. In vitro and in vivo effects.
    Raimond-Pironneau F; Morel E
    Biochimie; 1980; 62(2-3):187-90. PubMed ID: 6246966
    [No Abstract]   [Full Text] [Related]  

  • 62. Normal inhibition of mammary tumor metastasis in C3H/He mice.
    Vaage J; Donovan D; Loftus T
    Clin Exp Metastasis; 1991; 9(3):273-81. PubMed ID: 2060185
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Resting stages of the JB-1 ascites tumour in the irradiated mouse.
    Bichel P; Dombernowsky P
    Eur J Cancer (1965); 1975 Jun; 11(6):425-31. PubMed ID: 1172466
    [No Abstract]   [Full Text] [Related]  

  • 64. Tumor associated immunosuppression in mice bearing anaplastic carcinoma.
    Kapoor QS
    Immunol Commun; 1981; 10(1):45-58. PubMed ID: 7275166
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Inhibitory effect of metyrapone and deoxycorticosterone on C3H breast adenocarcinoma.
    Critselis AN; Rettura G; Levenson SM; Seifter E
    Clin Oncol; 1977 Dec; 3(4):339-44. PubMed ID: 598061
    [No Abstract]   [Full Text] [Related]  

  • 66. Inhibition of blastocyst outgrowth in vitro by serum from mice with ascites teratoma.
    Dunn GR
    J Reprod Fertil; 1974 Jul; 39(1):93-5. PubMed ID: 4852468
    [No Abstract]   [Full Text] [Related]  

  • 67. Organ weights of TE mice bearing Ehrlich ascites carcinoma growing in the solid form and of C3H mice bearing spontaneous mammary carcinoma.
    VON EHRENSTEIN G
    Experientia; 1958 Aug; 14(8):299-300. PubMed ID: 13574149
    [No Abstract]   [Full Text] [Related]  

  • 68. Characterization of a G1 inhibitor from old JB-1 ascites tumor fluid. Interaction with polyions and ion exchangers.
    Barfod NM; Bichel P
    Virchows Arch B Cell Pathol; 1976 Sep; 21(3):249-58. PubMed ID: 823703
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Stimulating effect of ascorbic acid on ascites tumor cell multiplication in vitro.
    Liotti FS; Bodo M; Talesa V
    J Cancer Res Clin Oncol; 1983; 106(1):69-70. PubMed ID: 6885899
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Pharmacologically active substances in malignant ascites fluid.
    Sykes JA
    Br J Pharmacol; 1970 Nov; 40(3):595P-596P. PubMed ID: 5497846
    [No Abstract]   [Full Text] [Related]  

  • 71. [Evaluation by an in vitro test of cellular immunity in individual mice during growth of an antigenic tumor].
    Youn JK; Barski G
    C R Acad Hebd Seances Acad Sci D; 1969 Jun; 268(24):2993-6. PubMed ID: 4979135
    [No Abstract]   [Full Text] [Related]  

  • 72. [Metabolic modifications, ex vivo, of tumor cells during the growth of an experimental ascites tumor of the C3H mouse].
    Frindel E; Blayo MC; Pocidalo JJ
    Eur J Cancer (1965); 1969 May; 5(2):85-9. PubMed ID: 5770298
    [No Abstract]   [Full Text] [Related]  

  • 73. Assessment of concanavalin A reactivity to murine ascites tumours by inhibition of tumour cell migration.
    Friberg S; Golub SH; Lilliehöök B; Cochran AJ
    Exp Cell Res; 1972 Jul; 73(1):101-6. PubMed ID: 5036977
    [No Abstract]   [Full Text] [Related]  

  • 74. Effect of subcellular fractions of ascites tumor cells on tumor-host relationship in mice.
    DAVIDSON EH; TOSTESON TR
    AMA Arch Pathol; 1959 Aug; 68(2):226-31. PubMed ID: 13669841
    [No Abstract]   [Full Text] [Related]  

  • 75. [A new rat ascites tumor showing fragments with histoid structure in the ascites fluid].
    WATANABE F; HIGASHI M
    Gan; 1957 Dec; 48(4):547-9. PubMed ID: 13524498
    [No Abstract]   [Full Text] [Related]  

  • 76. Enhancement and inhibition of the growth of tumor homoiotransplants by pretreatment of the hosts with various preparations of normal and tumor tissue.
    SNELL GD
    J Natl Cancer Inst; 1952 Dec; 13(3):719-29. PubMed ID: 13000413
    [No Abstract]   [Full Text] [Related]  

  • 77. An in situ assay system to measure ornithine decarboxylase activity in primary cultures of chicken osteoblasts: effects of bone-seeking hormones.
    Löwik CW; van Zeeland JK; Herrmann-Erlee MP
    Calcif Tissue Int; 1986 Jan; 38(1):21-6. PubMed ID: 3000545
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Effect of progressive neoplastic growth on the decarboxylation of DL-[1-14C]ornithine by lymphocytes from C3H/He tumor hosts.
    Vaage J; Agarwal S; Reinertsen JL
    Cancer Res; 1978 Aug; 38(8):2253-8. PubMed ID: 667820
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Endogenous tumor growth factor indicated by increased ornithine decarboxylase activity in malignant cells treated with host serum ascites fluid.
    Vaage J; Agarwal S
    Cancer Res; 1979 May; 39(5):1511-7. PubMed ID: 427794
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Effects of retinoic acid and juvenile hormone on the induction of ornithine decarboxylase activity by 12-O-tetradecanoylphorbol-13-acetate.
    Kensler TW; Verma AK; Boutwell RK; Mueller GC
    Cancer Res; 1978 Sep; 38(9):2896-9. PubMed ID: 679197
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.